Instructions for completing the following form:

• Please be aware that your application may be assessed by colleagues not from your field. Therefore, please write for a broad audience.
• Each section must be addressed briefly and concisely. In case one or more sections do not apply to a particular proposal, please provide a short explanation of why it is not of relevance. Do not add any additional sections or alter the order of sections.
• In case a requested information is currently not yet available (e.g. a clinical study is planned for a later stage of the project and it will be based on or influenced by future results of other studies), the foreseen input shall be described.
• Every section underlies a specific limitation of characters (including spaces). Make sure these limitations are met in the proposal. Please, do not consider the limited characters as a target! It is in your interest to keep your text as concise as possible.

*For information about our privacy policy, please click here.

{name}, {projectTitle}

 

{name}, {projectTitle}

 

{name}, {projectTitle}

 

Short summary of the planned research project (including a description of its innovative and interdisciplinary content, in relation to the current state of knowledge, in a generally understandable form, stating the problem addressed).

{name}, {projectTitle}

 

Template

Description of the planned project

• Subheadings shall include but are not limited to methodology, explanation of the test planning, data evaluation, schedule, persons working on the project, collaboration partners, any necessary official approval notices

Formal requirements

• Arial font 11, max. 3 outline levels
• Max. 5 pages incl. images | tables

 

{name}, {projectTitle}

 

Reference list of the most important project-relevant research work cited in the project description (max. 20 references).

{name}, {projectTitle}

 

Research questions, which potentially cover gender and gender-relevant components, have to address a balanced integration of the sexes when planning the experiment. Only applications in which male and female test subjects are involved will be funded. Male and female individuals have also to be used in laboratory animal tests. If this is not possible in individual cases, or if no gender-specific dimension has to be taken into account, or if there is a scientific / ethical reason not do to so, please provide a justification here.

{name}, {projectTitle}

 

{name}, {projectTitle}

 

{name}, {projectTitle}

 

{name}, {projectTitle}

 

Please specify for how many months the funding should be provided (funding for a PRE application can be provided for up to 6 months).

{name}, {projectTitle}

 

*Please find a template for the letter of confirmation for PMU here.

{name}, {projectTitle}

 

Please refer to the explanation of conflicts of interest following the guidelines of the PMU-RIF that defines a conflict of interest as follows:

Any possible effects of the funding decision on the applicant's own economic or other personal interests,their spouses or life partners, family members or people living in the same household are to be viewedas a conflict of interest. Further circumstances that can give rise to a conflict of interest are, paid orunpaid, cooperation between applicants and project-involved companies or profit-oriented institutions, onwhich the funding decision could have financial or personal effects, even outside the project in question.All payments that applicants or the persons named in sentence 2 have already received from thirdparties (including from non-profit institutions) in connection with the project in question must be disclosedwhen the application is submitted, as well as any intellectual property rights of the applicants or otherproject-involved persons and institutions that are project-relevant in the broad sense. All financialcommitments or payments by third parties to the applicants or the persons named in sentence 2 thatoccur later, in particular during the ongoing award procedure or after the commitment of funding by thePMU-RIF, must be disclosed immediately after their occurrence.

Article IV. f. of the Guidelines of the PMU-RIF

Template Proposal PMU-RIF PRE, rev. 1 Paracelsus Medical University